Jeroen van de Pol

128 Chapter 5.1 References [1] Velzel E, Heida JP, Cozijnsen M. Versterking van de zorgfunctie van openbaar apothekers. 28 maart 2018. URL: https://www.knmp.nl/downloads/rapport-versterking-van-de-zorgfunctie- van-openbaar-apothekers.pdf/view [2] V&VN arbeidsmarktonderzoek. Personeelstekorten in de zorg; Oplossingen van de werkvloer. 6 oktober 2017. URL: https://www.venvn.nl/Portals/1/Downloads/Personeelstekorten-zorg- oplossingen-van-de-werkvloer.pdf [3] Smith MA. Primary Care Teams and Pharmacist Staffing Ratios: Is There a Magic Number? Ann Pharmacother 2018;52:290-94. [4] Mossialos E, Courtin E, Naci H et al. From “retailers” to healthcare providers: Transforming the role of community pharmacists in chronic disease management. Health Policy 2015;119:628-39. [5] Eades CE, Ferguson JS, O’Carrol RE. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health 2011;11:582. [6] Hindi AMK, Schafheutle EI, Jacobs S. Community pharmacy integration within the primary care pathway for people with long-term conditions: a focus group study of patients', pharmacists' and GPs' experiences and expectations. BMC Fam Pract. 2019;20(1):26. [7] Armour CL, Smith L, Krass I. Community pharmacy, disease state management, and adherence to medication – A review. Dis Manag Health Outcome. 2008;16:245-254. [8] Cheema E, Sutcliffe P, Singer DR. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2014;78:1238-1247. [9] Lindenmeyer A, Hearnshaw H, Vermeire E et al. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Ther. 2006;31:409-419. [10] Bell S, McLachlan AJ, Aslani P et al. Community pharmacy services to optimise the use of medications for mental illness: a systematic review. Aust New Zealand Health Policy. 2005;2:29. [11] Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003;25:144-153. [12] Ensing HT, Koster ES, Dubero DJ et al. Collaboration between hospital and community pharmacists to address drug-related problems: The HomeCoMe-program. Res Social Adm Pharm. 2019;15(3):267-78. [13] Verdoorn S, Kwint HF, Hoogland P et al. Drug-related problems identified during medication review before and after the introduction of a clinical decision support system. J Clin Pharm Ther. 2018;43(2):224-231. [14] Van Eikenhorst L, Taxis K, van Dijk L et al. Pharmacist-Led Self-management Interventions to Improve Diabetes Outcomes. A Systematic Literature Review and Meta-Analysis. Front Pharmacol. 2017;8:891.